Dorothea Hanf
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.
Journal: Med (New York, N.Y.)
Published: September 04, 2024
Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma.
Journal: ESMO open
Published: August 16, 2024
Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markers.
Journal: Breast cancer research and treatment
Published: August 13, 2024
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology.
Journal: NPJ precision oncology
Published: April 02, 2023
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 06, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.
Journal: Nature communications
Published: March 05, 2021
Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3 G623R Solvent-Front Mutation.
Journal: JCO precision oncology
Published: July 15, 2020
Reproduction and breast cancer risk.
Journal: Breast care (Basel, Switzerland)
Published: March 12, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026